top of page

Michael Hamblin


Cofounder OmGeneum, ÉlpisÉremo, ARMADYNE.. widely recognized as the pioneer leading expert of Photobiomodulation. Fmr Associate Professor of Dermatology at Harvard Medical School, Faculty member of Harvard-MIT Health Science and Technology Division. Massachusetts General Hospital Fmr. Principal Investigator at Wellman Center for Photomedicine. He pioneered appli-cations of LLLT transcranial (NIR) light on the healing treatment of traumatic brain injury, stroke, Alzheimer’s dementia,  Parkinson’s neuro-degenerative diseases; depres-sion, anxiety, PTSD, autism, psychiatric disorders. Pioneering research includes: Mechanisms for Photobiomodulation to stimulate healing, prevent tissue death and relieve pain and inflammation

bottom of page